Drug intelligence / Profile preview

Britvit

Development stage: Unknown
Lead developer: Elbrit Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Britvit is an oral multivitamin and multimineral supplement developed and marketed by Elbrit Life Sciences. It is formulated as a tablet containing a comprehensive blend of essential vitamins, minerals, and antioxidants, including beta-carotene, biotin, choline, chromium, copper, manganese, zinc, ferrous fumarate, folic acid, lycopene, methylcobalamin, molybdenum, niacinamide, pyridoxine, selenium dioxide, taurine, magnesium, and vitamin D3. Britvit is primarily indicated for the management of nutritional deficiencies and to support skin health, particularly in the treatment of hyperpigmentation, by regulating cell metabolism and providing antioxidant protection against free radical damage.

Brand names: Britvit

Beyond the preview

Go deeper on Britvit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Britvit.

Explore the full profile